Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

ADALIMUMAB

  • Open Access
    Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry
    Leslie R. Harrold, Jenny Griffith, Patrick Zueger, Heather J. Litman, Bernice Gershenson, Syed S. Islam, Christine J. Barr, Dianlin Guo, Jonathan Fay and Jeffrey D. Greenberg
    The Journal of Rheumatology July 1 2020, 47 (7) 959-967; DOI: https://doi.org/10.3899/jrheum.190260
  • You have access
    Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
    Gurjit S. Kaeley, Daryl K. MacCarter, Aileen L. Pangan, Xin Wang, Jasmina Kalabic and Veena K. Ranganath
    The Journal of Rheumatology December 1 2018, 45 (12) 1628-1635; DOI: https://doi.org/10.3899/jrheum.171232
  • You have access
    Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis
    Linda A. Bradbury, Kelly A. Hollis, Benoît Gautier, Sateesh Shankaranarayana, Philip C. Robinson, Nivene Saad, Kim-Anh Lê Cao and Matthew A. Brown
    The Journal of Rheumatology June 1 2018, 45 (6) 771-778; DOI: https://doi.org/10.3899/jrheum.170312
  • Open Access
    Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab
    Philip J. Mease, Filip Van den Bosch, Joachim Sieper, Yinglin Xia, Aileen L. Pangan and In-Ho Song
    The Journal of Rheumatology May 1 2017, 44 (5) 599-608; DOI: https://doi.org/10.3899/jrheum.160387
  • You have access
    Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study
    Yosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Yuji Hirano, Takayoshi Fujibayashi, Kenya Terabe, Yuichiro Yabe, Hiroyuki Miyake, Takefumi Kato, Hideki Takagi, Masatoshi Hayashi, Takayasu Ito, Yasuhide Kanayama, Takeshi Oguchi, Nobunori Takahashi, Hisato Ishikawa, Koji Funahashi and Naoki Ishiguro
    The Journal of Rheumatology August 1 2016, 43 (8) 1475-1479; DOI: https://doi.org/10.3899/jrheum.151006
  • Open Access
    Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial
    Gurjit S. Kaeley, Amy M. Evangelisto, Midori J. Nishio, Sandra L. Goss, Shufang Liu, Jasmina Kalabic and Hartmut Kupper
    The Journal of Rheumatology August 1 2016, 43 (8) 1480-1489; DOI: https://doi.org/10.3899/jrheum.151009
  • You have access
    Longterm Clinical Outcomes in 420 Patients with Psoriatic Arthritis Taking Anti-tumor Necrosis Factor Drugs in Real-world Settings
    Florenzo Iannone, Simona Lopriore, Romano Bucci, Giuseppe Lopalco, Angela Chialà, Luca Cantarini and Giovanni Lapadula
    The Journal of Rheumatology May 1 2016, 43 (5) 911-917; DOI: https://doi.org/10.3899/jrheum.151042
  • Open Access
    Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study
    Frank Behrens, Michaela Koehm, Uta Arndt, Bianca M. Wittig, Gerd Greger, Diamant Thaçi, Eva Scharbatke, Hans-Peter Tony and Harald Burkhardt
    The Journal of Rheumatology March 1 2016, 43 (3) 632-639; DOI: https://doi.org/10.3899/jrheum.141596
  • You have access
    Clinical Remission in Patients with Active Psoriatic Arthritis Treated with Adalimumab and Correlations in Joint and Skin Manifestations
    Filip Van den Bosch, Arthur Kavanaugh, Martina Kron, Hartmut Kupper and Philip J. Mease
    The Journal of Rheumatology June 1 2015, 42 (6) 952-959; DOI: https://doi.org/10.3899/jrheum.140312
  • You have access
    Prevalence of TNF-α Blocker Immunogenicity in Psoriatic Arthritis
    Michael Zisapel, Devy Zisman, Noa Madar-Balakirski, Uri Arad, Hagit Padova, Hagit Matz, Hagit Maman-Sarvagyl, Ilana Kaufman, Daphna Paran, Joy Feld, Ira Litinsky, Irena Wigler, Dan Caspi and Ori Elkayam
    The Journal of Rheumatology January 1 2015, 42 (1) 73-78; DOI: https://doi.org/10.3899/jrheum.140685

Pages

  • Next
  • 1
  • 2

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire